BRCA1 CLIA Kit

Catalog No. ABIN6213031

Product Details BRCA1 CLIA Kit

Target: BRCA1 (Breast Cancer 1 (BRCA1))

Reactivity: Human

Detection Method: Chemiluminescent

Method Type: Sandwich ELISA

Detection Range: 0.156 ng/mL - 10 ng/mL

Minimum Detection Limit: 0.156 ng/mL

Application: ELISA

Purpose: Human Breast Cancer Susceptibility Protein 1 (BRCA1) CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates, cell lysates and other biological fluids.

Sample Type: Cell Lysate, Tissue Homogenate

Analytical Method: Quantitative

Sensitivity: < 0.065 ng/mL

Application Details

Application Notes:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plate: Pre-coated

Restrictions: For Research Use only

Handling

Storage: 4 °C/-20 °C

Storage Comment: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Expiry Date: 6 months

Target Details

Target: BRCA1 (Breast Cancer 1 (BRCA1))

Alternative Name: Breast Cancer Susceptibility Protein 1 (BRCA1) (BRCA1 Products)

Synonyms: BRCAI CLIA Kit, BRCC1 CLIA Kit, BROVCA1 CLIA Kit, IRIS CLIA Kit, PNCA4 CLIA Kit, PPP1R53 CLIA Kit, PSCP CLIA Kit, RNF53 CLIA Kit, iris CLIA Kit, pscp CLIA Kit, brcai CLIA Kit, brcc1 CLIA Kit, rnf53 CLIA Kit, brca1 CLIA Kit, BRCA1 CLIA Kit, LOC100224649 CLIA Kit, BRCA1, DNA repair associated CLIA Kit, breast cancer 1 CLIA Kit, breast cancer 1, early onset CLIA Kit, breast cancer 1 L homeolog CLIA Kit, BRCA1 CLIA Kit, brca1 CLIA Kit, LOC755086 CLIA Kit, Brca1 CLIA Kit, brca1.L CLIA Kit

Pathways: Cell Division Cycle, DNA Damage Repair, Intracellular Steroid Hormone Receptor Signaling Pathway, Positive Regulation of Response to DNA Damage Stimulus